Article result template
I'm a little template short and blank. I link to void and keep hidden out.
2025-03-28T10:09:50+0000
I'm a little template short and blank. I link to void and keep hidden out.
2025-03-28T10:09:50+0000
Now that the FTSE 100 hit a new all-time high amid a weak sterling and rate cut expectations, how much further can it rise?
2025-01-19T22:07:32+0000
Wesfarmers' sale of Coregas for $770 million marks a strategic shift in asset management, impacting its valuation and future growth strategies on the ASX.
2024-12-20T03:19:50+0000
Metcash sees stable supermarket growth, but hardware and liquor struggle, prompting a hold recommendation despite acquisition boosts.
2024-12-11T05:34:31+0000
Integral Diagnostics strengthens its market position by acquiring Capital Health, approved by ASIC. The merger presents significant investment opportunities due to undervaluation.
2024-12-11T04:42:45+0000
Discover why Pro Medicus (ASX: PME) is captivating investors with a record-breaking $330 million contract, strong momentum, and analyst upgrades despite valuation concerns.
2024-12-05T03:10:47+0000
This year is thought to be a turnaround year for the Hang Seng Index, but doubts on the recovery prospects for Hong Kong's markets have resurfaced lately.
2024-11-20T04:57:25+0000
TechnologyOne achieves a 15% profit increase, driven by strong UK sales and Software as a Service growth. With their ambitious revenue goals, the company presents a compelling case for long-term investors.
2024-11-19T04:01:24+0000
Aristocrat Leisure’s net profit rose 17%, backed by strong North American results and strategic moves. With a growing dividend, Aristocrat presents an attractive investment outlook.
2024-11-13T05:04:55+0000
New client: +65 6390 5133 or accountopening@ig.com.sg
Clients: Help and support
WhatsApp: Click here
Follow us online:
Disclaimer:
All forms of investments carry risks and trading CFDs may not be suitable for everyone. CFDs are leveraged instruments and can result in losses that exceed deposits, so please ensure that you fully understand, and are aware of, the risks and costs involved. Refer to the Risk Disclosure Statement and Risk Fact Sheet.
IG Asia Pte Ltd (Co.Reg.No. 200510021K) is regulated by the Monetary Authority of Singapore and holds a capital markets services licence for dealing in capital markets products that are over-the-counter derivatives contracts and is an exempt financial adviser.
IG provides an execution-only service. The information in this advertisement does not contain (and should not be construed as containing) investment advice or an investment recommendation, or an offer of or solicitation for a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. You should consider your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
The information on this site is not directed at residents of the United States or Belgium and is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
This advertisement has not been reviewed by the Monetary Authority of Singapore.